January 22, 2025
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
New headquarters supports Novocure’s continued growth as it pursues its mission of extending survival in some of the most aggressive forms of cancer BAAR, Switzerland–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today the official opening of its new global headquarters in the Canton of Zug, Switzerland. Novocure… Read More
learn more
January 13, 2025
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
Preliminary full year 2024 net revenues of $605 million and fourth quarter net revenues of $161 million Novocure to present at the 43rd Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PST on Wednesday, January 15, 2025 BAAR, Switzerland–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR)… Read More
learn more
January 3, 2025
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
BAAR, Switzerland–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive Officer, and William Doyle, Executive Chairman, will speak on behalf of the company and address questions at 9:00 a.m. Read More
learn more
